Panbela Therapeutics Inc (PBLA) Annual Balance Sheets

Annual · GAAP · USD millions
Access PBLA quarterly Balance Sheets →
A period-by-period view of the balance sheet from Panbela Therapeutics Inc to Dec 31 2019 helps clarify how Dec 31 2023's financial structure has changed over time.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2023)
(Dec 31 2022) (Dec 31 2021) (Dec 31 2020) (Dec 31 2019)
Assets
Cash & cash equivalent2.58
Cash & Short-term Investments2.00
Income Taxes Receivable, Current NO0.18
Other Current Assets0.00
Prepaid Expense, Current AS0.30
Total Current Assets3.06
Other Assets, Noncurrent8.00
Total Assets11.80
Liabilities
Accounts Payable, Current AC9.94
Accrued Liabilities, Current1.14
Notes Payable, Current NO0.00
Other Liabilities, Current1.24
Total Current Liabilities12.32
Long-term debt4.19
Total Long-term Debt4.19
Unsecured Promissory Note Payable Current-
Total Liabilities16.51
Stockholders' Equity
Treasury Stock Common Value0.00
Common Stock Value0.00
Additional Paid In Capital Common Stock120.04
Retained Earnings / Accumulated Deficit-125.50
Other Equity0.75
Common Stockholder's Equity-4.71
Total Stockholder's Equity-4.71
Liabilities & Stockholder's Equity11.80
4 historic quarters locked

Sign in to unlock the full Panbela Therapeutics Inc balance sheet history.

About Panbela Therapeutics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001437749-24-009418

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License